April 2017 - Volume 40 - Issue 2

  • David E. Wazer, MD
  • 0277-3732
  • 1537-453X
  • 6 issues per year
  • Oncology 101/213
  • 2.977

Current Issue Highlights

ACR Appropriateness Criteria(R)

ACR Appropriateness Criteria® Resectable Pancreatic Cancer

Jones, William E. III; Suh, W. Waren; Abdel-Wahab, May; More

American Journal of Clinical Oncology . 40(2):109-117, April 2017.

Symptom Management

The Efficacy of Palonosetron Plus Dexamethasone in Preventing Chemoradiotherapy-induced Nausea and Emesis in Patients Receiving Daily Low-dose Cisplatin-based Concurrent...

Mitsuhashi, Akira; Usui, Hirokazu; Nishikimi, Kyoko; More

American Journal of Clinical Oncology . 40(2):118-121, April 2017.

Experimental Therapeutics

Gene Expression Profiling of Tumors From Heavily Pretreated Patients With Metastatic Cancer for the Selection of Therapy: A Pilot Study

Rebollo, Joseba; Sureda, Manuel; Martinez, Elena M.; More

American Journal of Clinical Oncology . 40(2):140-145, April 2017.





Soft Tissue

Evaluating the Role of Interdigitated Neoadjuvant Chemotherapy and Radiation in the Management of High-Grade Soft-Tissue Sarcoma: The Johns Hopkins Experience

Raval, Raju R.; Frassica, Deborah; Thornton, Katherine; More

American Journal of Clinical Oncology . 40(2):214-217, April 2017.